Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.48 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | RAD52 | P43351 | 1/20 | 0.36 |
| ▸ | CHKA | P35790 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13833227 | 0.98 | KDM4E (0.56) | KDM4ECHRM5CHRM3SIGMAR1POLB | |
| SCHEMBL422666 | 0.98 | KDM4E (0.56) | KDM4ECHRM5CHRM3SIGMAR1POLB | |
| Piperazine SCHEMBL28219481 | 0.95 | KDM4E (0.54) | KDM4ECHRM5CHRM3SIGMAR1POLB | |
| Hydrochloric Acid SCHEMBL4681 | 0.95 | KDM4E (0.54) | KDM4ECHRM5CHRM3SIGMAR1POLB | |
| Hydrochloric Acid SCHEMBL1546636 | 0.95 | KDM4E (0.54) | KDM4ECHRM5CHRM3SIGMAR1POLB | |
| SCHEMBL10615036 | 0.95 | KDM4E (0.54) | KDM4ECHRM5CHRM3SIGMAR1POLB | |
| SCHEMBL3832605 | 0.95 | KDM4E (0.54) | KDM4ECHRM5CHRM3SIGMAR1POLB | |
| SCHEMBL22266260 | 0.94 | KDM4E (0.53) | KDM4ECHRM5CHRM3SIGMAR1POLB | |
| SCHEMBL25518168 | 0.92 | KDM4E (0.47) | KDM4ECHRM5CHRM3SIGMAR1POLB | |
| SCHEMBL15043632 | 0.92 | SIGMAR1 (0.48) | KDM4ECHRM5CHRM3SIGMAR1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346589-A1 | RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS | UNIV ERASMUS MED CT ROTTERDAM (NL) | 2025-11-13 | — | — | US | claimed |
| US-20250288704-A1 | CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF | Technische Universität München (DE) | 2025-09-18 | — | — | US | claimed |
| US-20250135047-A1 | IMPROVED ALUMINUM FLUORIDE RADIOSYNTHESIS OF [18F]DK222 | THE JOHNS HOPKINS UNIVERSITY | 2025-05-01 | — | — | US | claimed |
| EP-4529474-A1 | RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS | Erasmus University Rotterdam Medical Center (NL) | 2025-04-02 | — | — | EP | claimed |
| WO-2025024887-A1 | DOSAGE REGIMEN FOR SHORT-LIVED RADIOISOTOPE | AdvanCell Isotopes Pty Limited (AU) | 2025-02-06 | — | — | WO | claimed |
| US-20240374630-A1 | COMPOSITION FOR CAPTURING LEAD AND/OR CADMIUM IN A DIALYSIS FLUID | UNIVERSITE CLAUDE BERNARD LYON 1 (FR) | 2024-11-14 | — | — | US | claimed |
| WO-2024206972-A1 | COMPOUNDS AND COMBINATIONS FOR DIAGNOSING AND TREATING MELANOMA AND METHODS RELATED TO THE SAME | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2024-10-03 | — | — | WO | claimed |
| US-20240317780-A1 | RADIOPHARMACEUTICAL SOMATOSTATIN RECEPTOR LIGANDS AND PRECURSORS THEREOF | Technische Universität München (DE) | 2024-09-26 | — | — | US | claimed |
| CN-117320759-A | Radiopharmaceutical somatostatin receptor ligands and precursors thereof | 慕尼黑工业大学 | 2023-12-29 | — | — | CN | claimed |
| EP-4291252-A1 | CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF | Technische Universität München (DE) | 2023-12-20 | — | — | EP | claimed |
| EP-4069311-A1 | REACTIVE CONJUGATES | Debiopharm Research & Manufacturing SA (CH) | 2022-10-12 | — | — | EP | claimed |
| US-20220287658-A1 | IN VIVO IMMUNOIMAGING OF INTERLEUKIN-12 | WAYNE STATE UNIVERSITY (US) | 2022-09-15 | — | — | US | claimed |
| WO-2022171869-A1 | CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF | Technische Universität München (DE) | 2022-08-18 | — | — | WO | claimed |
| EP-4043041-A1 | CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF | Technische Universität München (DE) | 2022-08-17 | — | — | EP | claimed |
| EP-4017534-A1 | IN VIVO IMMUNOIMAGING OF INTERLEUKIN-12 | Wayne State University (US) | 2022-06-29 | — | — | EP | claimed |
| WO-2022079031-A1 | REACTIVE CONJUGATES | DEBIOPHARM RESEARCH & MANUFACTURING S.A. (CH) | 2022-04-21 | — | — | WO | claimed |
| WO-2022078566-A1 | REACTIVE CONJUGATES | DEBIOPHARM RESEARCH & MANUFACTURING S.A. (CH) | 2022-04-21 | — | — | WO | claimed |
| WO-2022032100-A2 | IMAGING AND TARGETING PROGRAMMED DEATH LIGAND-1 (PD-LI) EXPRESSION | THE JOHNS HOPKINS UNIVERSITY (US) | 2022-02-10 | — | — | WO | claimed |
| WO-2022018264-A1 | SILICON-CONTAINING LIGAND COMPOUNDS | Technische Universität München (DE) | 2022-01-27 | — | — | WO | claimed |
| WO-2021034943-A1 | IN VIVO IMMUNOIMAGING OF INTERLEUKIN-12 | WAYNE STATE UNIVERSITY (US) | 2021-02-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346589-A1 | RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS | SSTR2, SSTR5, SSTR1 | KDM4E 3216/4885CHRM5 709/4885CHRM3 532/4885 |
| US-20240374630-A1 | COMPOSITION FOR CAPTURING LEAD AND/OR CADMIUM IN A DIALYSIS FLUID | SLC30A7, CD63, SLC30A5 | KDM4E 3910/4885CHRM5 3444/4885CHRM3 3661/4885 |
| US-20220287658-A1 | IN VIVO IMMUNOIMAGING OF INTERLEUKIN-12 | IL2, IFNG, CD47 | KDM4E 4222/4885CHRM5 3625/4885CHRM3 3140/4885 |
| US-20250288704-A1 | CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF | CXCR4, CXCR1, CXCR3 | KDM4E 4312/4885CHRM5 931/4885CHRM3 657/4885 |
| US-20250135047-A1 | IMPROVED ALUMINUM FLUORIDE RADIOSYNTHESIS OF [18F]DK222 | PDCD1LG2, CD274, PDCD1 | KDM4E 3235/4885CHRM5 4804/4885CHRM3 4669/4885 |
| US-20240317780-A1 | RADIOPHARMACEUTICAL SOMATOSTATIN RECEPTOR LIGANDS AND PRECURSORS THEREOF | SSTR1, SSTR3, SSTR4 | KDM4E 4286/4885CHRM5 2558/4885CHRM3 1432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.